Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In-host adaptation and acquired triazole resistance in Aspergillus fumigatus : a dilemma for clinical management
Paul E. Verweij, Jianhua Zhang, Alfons J. M. Debets, et al.
The Lancet Infectious Diseases (2016) Vol. 16, Iss. 11, pp. e251-e260
Closed Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

Aspergillus fumigatus and Aspergillosis in 2019
Jean‐Paul Latgé, Georgios Chamilos
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 864
Clinical implications of globally emerging azole resistance in Aspergillus fumigatus
Jacques F. Meis, Anuradha Chowdhary, Johanna Rhodes, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2016) Vol. 371, Iss. 1709, pp. 20150460-20150460
Open Access | Times Cited: 274
Azole-Resistant Aspergillosis: Epidemiology, Molecular Mechanisms, and Treatment
Anuradha Chowdhary, Cheshta Sharma, Jacques F. Meis
The Journal of Infectious Diseases (2017) Vol. 216, Iss. suppl_3, pp. S436-S444
Open Access | Times Cited: 227
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Amir Arastehfar, Toni Gabaldón, Rocio Garcia‐Rubio, et al.
Antibiotics (2020) Vol. 9, Iss. 12, pp. 877-877
Open Access | Times Cited: 212
Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management
Pieter P. A. Lestrade, Jacques F. Meis, Willem J. G. Melchers, et al.
Clinical Microbiology and Infection (2018) Vol. 25, Iss. 7, pp. 799-806
Open Access | Times Cited: 165
Aspergillus fumigatusand aspergillosis: From basics to clinics
Amir Arastehfar, Agostinho Carvalho, Jos Houbraken, et al.
Studies in Mycology (2021) Vol. 100, Iss. 1, pp. 100115-100115
Open Access | Times Cited: 165
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen, Elke H. J. Krekels, Paul E. Verweij, et al.
Drugs (2020) Vol. 80, Iss. 7, pp. 671-695
Open Access | Times Cited: 139
Triazole resistance surveillance in Aspergillus fumigatus
Agustin Reséndiz-Sharpe, Katrien Lagrou, Jacques F. Meis, et al.
Medical Mycology (2017) Vol. 56, Iss. suppl_1, pp. S83-S92
Open Access | Times Cited: 141
A Novel Environmental Azole Resistance Mutation in Aspergillus fumigatus and a Possible Role of Sexual Reproduction in Its Emergence
Jianhua Zhang, Eveline Snelders, Bas J. Zwaan, et al.
mBio (2017) Vol. 8, Iss. 3
Open Access | Times Cited: 115
The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda
Paul E. Verweij, John A. Lucas, Maiken Cavling Arendrup, et al.
Fungal Biology Reviews (2020) Vol. 34, Iss. 4, pp. 202-214
Open Access | Times Cited: 109
Current antifungal treatment of fusariosis
Abdullah M. S. Al‐Hatmi, Alexandro Bonifáz, Stéphane Ranque, et al.
International Journal of Antimicrobial Agents (2017) Vol. 51, Iss. 3, pp. 326-332
Open Access | Times Cited: 105
Molecular Mechanisms of Conidial Germination in Aspergillus spp
Tim Baltussen, Jan Zoll, Paul E. Verweij, et al.
Microbiology and Molecular Biology Reviews (2019) Vol. 84, Iss. 1
Open Access | Times Cited: 93
Nonrandom Distribution of Azole Resistance across the Global Population of Aspergillus fumigatus
Thomas R. Sewell, Jianing Zhu, Johanna Rhodes, et al.
mBio (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 90
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi
Margriet W.J. Hokken, Bas J. Zwaan, Willem J. G. Melchers, et al.
Fungal Genetics and Biology (2019) Vol. 132, pp. 103254-103254
Open Access | Times Cited: 76
Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond
Rafael Wesley Bastos, Luana Rossato, Gustavo H. Goldman, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010073-e1010073
Open Access | Times Cited: 76
Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications
Thomas R. Rogers, Paul E. Verweij, Mariana Castanheira, et al.
Journal of Antimicrobial Chemotherapy (2022) Vol. 77, Iss. 8, pp. 2053-2073
Open Access | Times Cited: 55
Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO)
Markus Ruhnke, Gerhard Behre, Dieter Buchheidt, et al.
Mycoses (2018) Vol. 61, Iss. 11, pp. 796-813
Open Access | Times Cited: 80
In-host microevolution of Aspergillus fumigatus: A phenotypic and genotypic analysis
Eloise Ballard, Willem J. G. Melchers, Jan Zoll, et al.
Fungal Genetics and Biology (2018) Vol. 113, pp. 1-13
Open Access | Times Cited: 74
Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance
Yeqi Li, Yuanwei Zhang, Chi Zhang, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 117, Iss. 3, pp. 1711-1721
Open Access | Times Cited: 64
Mechanisms of triazole resistance in Aspergillus fumigatus
Ashley V. Nywening, Jeffrey M. Rybak, P. David Rogers, et al.
Environmental Microbiology (2020) Vol. 22, Iss. 12, pp. 4934-4952
Open Access | Times Cited: 51
Resistance profiling of Aspergillus fumigatus to olorofim indicates absence of intrinsic resistance and unveils the molecular mechanisms of acquired olorofim resistance
Jochem B. Buil, Jason D. Oliver, Derek Law, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 703-714
Open Access | Times Cited: 35
Recent Advances in Fungal Infections: From Lung Ecology to Therapeutic Strategies With a Focus on Aspergillus spp.
Fabio Palmieri, Angela Koutsokera, Eric Bernasconi, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 29
Most azole resistance mutations in the Candida albicans drug target confer cross-resistance without intrinsic fitness cost
Camille Bédard, Isabelle Gagnon‐Arsenault, Jonathan Boisvert, et al.
Nature Microbiology (2024) Vol. 9, Iss. 11, pp. 3025-3040
Closed Access | Times Cited: 8
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999–2015
Sang Taek Heo, Alexander M. Tatara, Cristina Jiménez‐Ortigosa, et al.
Clinical Infectious Diseases (2017) Vol. 65, Iss. 2, pp. 216-225
Open Access | Times Cited: 60
Evolution of cross-resistance to medical triazoles inAspergillus fumigatusthrough selection pressure of environmental fungicides
Jianhua Zhang, Joost van den Heuvel, Alfons J. M. Debets, et al.
Proceedings of the Royal Society B Biological Sciences (2017) Vol. 284, Iss. 1863, pp. 20170635-20170635
Open Access | Times Cited: 56
Page 1 - Next Page

Scroll to top